(Total Views: 570)
Posted On: 05/06/2020 10:55:49 AM
Post# of 148890
Z_smith:
Very valid question. The short answer is that it is difficult to know at what time was the cited rate obtained. It seems that there is a mixture as the number of patient was large (5700). However, we can expect that those who passed away had similar time spans as those in Montefiore (or probably less for the Montefiore study as they here treated as last resort as IND).
RESULTS
Very valid question. The short answer is that it is difficult to know at what time was the cited rate obtained. It seems that there is a mixture as the number of patient was large (5700). However, we can expect that those who passed away had similar time spans as those in Montefiore (or probably less for the Montefiore study as they here treated as last resort as IND).
RESULTS
Quote:
A total of 5700 patients were included (median age, 63 years [interquartile range {IQR}, 52-75; range, 0-107 years]; 39.7%female). The most common comorbidities were hypertension (3026; 56.6%), obesity (1737; 41.7%), and diabetes (1808; 33.8%).
At triage, 30.7%of patients were febrile, 17.3%had a respiratory rate greater than 24 breaths/minute, and 27.8%received supplemental oxygen. The rate of respiratory virus co-infection was 2.1%.
Outcomes were assessed for 2634 patients who were discharged or had died at the study end point. During hospitalization, 373 patients (14.2%) (median age, 68 years [IQR, 56-78]; 33.5%female) were treated in the intensive care unit care, 320 (12.2%) received invasive mechanical ventilation, 81 (3.2%) were treated with kidney replacement therapy, and 553 (21%) died.
As of April 4, 2020, for patients requiring mechanical ventilation (n = 1151, 20.2%), 38 (3.3%) were discharged alive, 282 (24.5%) died, and 831 (72.2%) remained in hospital. The median post discharge follow-up time was 4.4 days (IQR, 2.2-9.3). A total of 45 patients (2.2%) were readmitted during the study period. The median time to readmission was 3 days (IQR, 1.0-4.5) for readmitted patients. Among the 3066 patients who remained hospitalized at the final study follow-up date (median age, 65 years [IQR, 54-75]), the median follow-up at time of censoring was 4.5 days (IQR, 2.4-8.1).
(0)
(0)
Scroll down for more posts ▼